NOW AVAILABLE IN EUROPE
PreFree:
Prediction of Preeclampsia-Associated Risks
Smarter Decisions. Safer Pregnancies.
Revolutionizing Care for Women and Children
Next-Generation Clinical Decision Support Powered by Predictive Analytics
NeoPredics is transforming clinical decision support, delivering personalized solutions that optimize care for women and children. Our cutting-edge technology empowers clinicians to predict health risks earlier, facilitating timely, sometimes life-saving interventions for mothers and their babies.
A Breakthrough in Maternal and Neonatal Health.
By identifying risks before they become critical, NeoPredics enables healthcare providers to make proactive, informed decisions that improve patient outcomes, prioritize safety, and reduce costs for both hospitals and families. Discover how NeoPredics is leading the charge in advancing care for women and children. Contact us to learn how your institution can benefit from the future of personalized medicine.
Our Products and Projects
Explore our innovations designed to improve maternal and neonatal health. Join us in redefining the standards of care for women and their newborns.
BiliPredics
Advanced bilirubin prediction software
BiliPredics converts clinical data into scientifically validated predictions to help physicians and clinical professionals make faster and more accurate decisions when caring for newborns at risk of jaundice.
PreFree
Prediction of preeclampsia-associated
PreFree is the first multimodal, CE-marked prediction model that combines biomarkers (sFlt-1/PlGF) with clinical data enabling reliable risk stratification for pregnant women at an early stage, including remote patient monitoring directly from home.
Our Mission & Vision
Advancing Clinical Decision Making
for Women and Children
At NeoPredics, we are not just predicting outcomes, we change them. Our mission is to arm clinicians with accurate predictions, turning complex data into simple, actionable steps that protect mothers and babies when it matters most. Precision isn’t our goal - it’s our standard.
A New Frontier in Health Outcomes
We believe that the future of maternal and neonatal care lies in early intervention and personalized medicine. By identifying potential health risks well in advance, our tools equip healthcare providers with the insights needed to make timely, sometimes life-saving decisions. This personalized approach enhances patient safety, improves care quality, and reduces healthcare costs, benefiting both hospitals and families.
Empowering Clinicians Worldwide
NeoPredics envisions a healthcare landscape where every clinician has access to cutting-edge tools that are personalized, predictive, and scientifically validated. Our technology serves as a critical asset in making complex medical decisions easier, globally.
The team of experts
Experience for progress -
a highly qualified leadership team
Thorsten Waloschek
CEO US / Germany
Senior industry executive
President of Draeger Medical Neonatal Care and Vice President of Draeger Medical USA
Head of marketing and new business development at NATUS
Co-founder of InfanDx
Jörg Schmidt
CFO
Senior financial executive in Life Sciences and MedTech industries
Experience at Ernst & Young
Focus on bringing innovative companies and their products to market successfully
Mark Heuring
Marketing / Sales
Healthcare executive with 20+ years' global experience in medical devices, OEM partnerships, and EMEA market distribution
Marvin Häberle
Product Manager
Graduate of ETH Zurich/CH – a leading global university in technology
Product Manager with a strong foundation in data science, AI-driven healthcare, and startup innovation
Dedicated to advancing digital solutions and clinical decision support in patient care
Viktor Ruder
Head of IT
Front- and backend programming, IT-infrastructure and web hosting, experience in SaaS
Lia Butler
Director Sales USA
Senior sales executive with start-up and neonatal medtech experience, former Client Executive Astarte Medical
Judy Moore
Sales Consultant
STRATEGIC ADVISORS
Advisory Board
Prof. Stefan Verlohren, Vorsitzender
Germany
Professor and Director of the Department of Obstetrics and Fetal Medicine at the University Hospital Hamburg Eppendorf, Germany.
Maternal-Fetal Medicine Specialist
Expert in women's health with focus on the diagnosis and management of preeclampsia and eclampsia.
Prof. Julia Vogt
ETH Zurich, Switzerland
Senior industry executive
Professor of Computer Science at ETH Zurich
Expert in machine learning for clinical data analysis and precision medicine
Dr. Dongli Song
Medical Director, USA
Medical Director Neonatology
Santa Clara Valley Hospital
Dr. Jonathan Palma
Orlando Health Winnie Palmer Hospital
Doctor of neonatology and perinatal medicine at Winnie Palmer Hospital for Women & Babies (NICU)
Clinical informaticist at Orlando Health
Newborn intensive care and enhancements to patient care quality and provider experience
Gilbert Koch
Clinical Pharmacologist
Senior Research Fellow in Pediatric Clinical Pharmacology, University of Basel, UKBB
Adjunct Assistant Professor, State University of New York at Buffalo – School of Pharmacy with >10 years of experience in pharmacokinetic and pharmacodynamic modeling
Board Members
Todd Usen, Chair
President & CEO Adagio Medical Inc.
Chairman at MassMEDIC and Rob Surgical
Director of Board of Directors Alesi Surgical Ltd....
Christine Storm, Deputy Chair
Germany
Senior industry executive
Business leader virtual care solutions at Philips
Expertise in scale-up of start ups
Dr. Gerhard Ries
Switzerland
Serial entrepreneur
CEO Kineo Finance
Investor
Jörg Schmidt
Switzerland
Senior financial executive in Life Sciences and MedTech industries
Experience at Ernst & Young
Focus on bringing innovative companies and their products to market successfully
Arne Kirchner
Switzerland, Germany
Founder of Alp Financial Services
Asset management
Investment banking
Investor
Prof. Dr. Sven Wellmann
Switzerland
Medical Director Dept. of Neonatology and Perinatal Center Regensburg
Leading researcher
Experience at Charité, UKBB Basel, University of Zurich, University of Regensburg
Prof. Dr. Marc Pfister
Switzerland
Clinician, researcher, innovator and entrepreneur
Head of the department of pharmacometrics at the University Children’s Hospital in Basel, Switzerland
Experience at Sanofi-Aventis, Bristol-Myers Squibb, University of Basel
Career Opportunities
Join our growing team and design a future of medicine!
Spun off successfully from the University of Basel, NeoPredix is a young and innovative startup in the medical technology software field. We are developing new, individualized treatment solutions to enhance perinatal and neonatal care. A diverse and motivated team, we are looking for independent, self-motivated individuals who are passionate about using software to improve the lives of children and their families. If this intrigues you, please explore our options below, reach out to us on LinkedIn, or send us your resume at
CONNECT WITH US
Learn more about NeoPredics
by contacting us
NeoPredics AG (Switzerland)
Rittergasse 22, 4051 Basel, Switzerland
Executive Board: Jörg Schmidt, Dr. Gerhard Ries
Registered Office: Basel
Commercial register number: CH-270.3.016.001-3
Chairman of the board: Todd Usen
NeoPredics USA, Inc. (US)
110 E Broward Blvd #1700
Fort Lauderdale, FL 33301, United States
Executive Board: Thorsten Waloschek, Todd Usen
NeoPredics AG (Germany)
Franz-Mayer-Straße 1, 93053 Regensburg
Executive Board: Thorsten Waloschek (chairman), Jörg Schmidt
Registered Office: Regensburg
Commercial register number: HRB 18679
Supervisory Board: Todd Usen (chairman), Christine Storm, Dr. Gerhard Ries, Arne Kirchner, Prof. Dr. Sven Wellmann
